Trials supporting FDA approval of breakthrough drugs examined
(HealthDay)—Pivotal trials supporting U.S. Food and Drug Administration approvals granted Breakthrough Therapy designation often lack randomization, double-blinding, and control groups, according to a
Updated on: April 14,2024
18

Trials supporting FDA approval of breakthrough drugs examined
(HealthDay)—Pivotal trials supporting U.S. Food and Drug Administration approvals granted Breakthrough Therapy designation often lack randomization, double-blinding, and control groups, according to a
Updated on:April 14,2024
18
